# Inhibrx Biosciences, Inc.: Form 8-K, filed Mar 19, 2026

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: 8-K
- Filed: 2026-03-19
- Accepted by EDGAR: Mar 19, 2026, 20:01 ET
- Period: 2026-03-19
- Accession: 0002007919-26-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000007/inhibrx-20260319.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000007/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000200791926000007/inhibrx-20260319.htm

Filed Mar 19, 2026.
Source: SEC EDGAR, the filing index for accession 0002007919-26-000007. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.